Similarly, Häusler and colleagues demonstrated that in human primary ovarian cancer cells and cell lines, CD73 and/or CD39 siRNA or small-molecule inhibitors enhanced NK-mediated cytotoxic T-cell activity and CD4+ T cell proliferation [22]; see Figure 1. This evidence concerns the gene ENTPD1 and ovarian carcinoma.